EUClinicalTrials.govClinical trialNot applicableRecruiting
CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA)
Official record
- Identifier
NCT07809659- Recruiting locations
countries
CzechiaGreeceLithuaniaPortugal- Interventions studied
- CanRiskStandard clinical risk assessment
- Lead sponsor
- Instituto Portugues Oncologia de Lisboa Francisco Gentil
- Target enrolment
- 2130 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Recruiting
- First posted
- Sep 9, 2026
- Last updated on the registry
- Sep 29, 2026
- Age
- 18 Years – 75 Years
- Sex
- FEMALE
- Study contact
- The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: 1. Women, trans men, non-binary people with female reproductive organs 2. Aged 18 to 75 years 3. Referred or self-referred because of a family history suggestive of increased risk for ovarian, fallopian tube or peritoneum cancer, or because a family member has been found to have a PV associated with OC risk 4. Able to give informed consent 5. Expected to remain in the study catchment area for the duration of follow-up. Exclusion Criteria: 1. Personal history of cancer 2. Previously undergone Risk-Reducing Salpingo-Oophorectomy (RRSO) 3. Previously undergone multifactorial risk assessment (using CanRisk or another tool) incorporating risk factors, family history and genetic testing (panel +/- PGS) 4. Any condition or circumstance that, in the opinion of the investigator, could interfere with the participant's ability to participate or comply with study requirements
- Indexed under
- Ovarian Cancer